patient
acut
exacerb
chronic
obstruct
pulmonari
diseas
aecopd
develop
acut
respiratori
failur
arf
requir
invas
mechan
ventil
assist
spontan
breath
sustain
life
although
effect
observ
studi
indic
protract
invas
ventil
may
pose
risk
complic
sinus
respiratori
muscl
weak
ventilatorassoci
pneumonia
vap
vap
close
relat
increas
mortal
morbid
mitig
complic
associ
prolong
invas
ventil
use
noninvas
ventil
shift
invas
support
noninvas
support
patient
consid
readi
extub
readi
remov
mechan
ventil
investig
benefit
reduc
durat
invas
ventil
incid
vap
mortal
rate
meanwhil
optim
time
use
noninvas
ventil
key
factor
success
treatment
arf
aecopd
patient
prematur
extub
immedi
applic
noninvas
ventil
caus
loss
airway
protect
respiratori
muscl
overload
fatigu
well
suboptim
ga
exchang
defer
use
noninvas
support
may
increas
risk
advers
complic
therefor
optim
time
must
care
chosen
achiev
balanc
potenti
risk
associ
earli
remov
invas
ventil
delay
applic
noninvas
ventil
pulmonari
infect
control
pic
window
recent
identifi
wang
et
al
may
select
appropri
time
replac
invas
ventil
noninvas
ventil
receiv
invas
ventil
adequ
antibiot
day
patient
pulmonari
infect
substanti
control
follow
indic
present
signific
decreas
infecti
infiltr
demonstr
lung
radiographi
notic
chang
phlegm
less
amount
lower
tenac
lighter
white
color
least
one
follow
sign
bodi
temperatur
peripher
white
blood
count
wbc
wbc
reduc
period
time
refer
pic
window
previou
studi
indic
noninvas
ventil
use
time
significantli
reduc
durat
invas
ventil
vap
hospit
death
aecopd
patient
arf
howev
recent
random
control
trial
rct
found
signific
differ
mortal
wean
failur
reintub
rate
patient
receiv
noninvas
ventil
continu
invas
ventil
recent
metaanalysi
found
use
noninvas
ventil
pic
window
associ
lower
mortal
lower
vap
incid
shorter
invas
ventil
time
grade
recommend
assess
develop
evalu
grade
approach
provid
instrument
rate
qualiti
evid
within
systemat
review
guidelin
gener
evidencebas
recommend
clinic
practic
guidelin
develop
tool
design
investig
current
altern
intervent
manag
strategi
includ
treatment
best
manag
review
guidelin
five
methodolog
factor
risk
bia
inconsist
indirect
imprecis
public
bia
judg
downgrad
upgrad
qualiti
evid
systemat
review
guidelin
develop
use
method
apprais
qualiti
evid
outcom
across
studi
also
call
bodi
evid
ultim
qualiti
bodi
evid
grade
level
high
moder
low
low
despit
fact
mani
public
explor
effect
noninvas
ventil
use
pic
window
arf
aecopd
patient
conclus
trial
inconsist
safeti
longterm
effect
intervent
still
remain
uncertain
addit
qualiti
avail
evid
apprais
critic
grade
approach
aim
studi
comprehens
investig
efficaci
safeti
intervent
grade
qualiti
present
evid
determin
recommend
practic
use
grade
approach
rct
publish
unpublish
english
chines
identifi
review
particip
age
year
old
malefemal
diagnos
aecopd
mainli
caus
pulmonari
infect
met
indic
use
mechan
ventil
includ
studi
diagnost
criteria
aecopd
could
follow
criteria
standard
diagnosi
treatment
chronic
obstruct
pulmonari
diseas
draft
edit
guidelin
diagnosi
treatment
chronic
obstruct
pulmonari
diseas
revis
global
strategi
diagnosi
manag
prevent
chronic
obstruct
pulmonari
diseas
revis
updat
patient
complic
pulmonari
encephalopathi
pulmonari
infarct
allerg
rhiniti
bronchial
asthma
activ
tuberculosi
pneumoconiosi
contraind
noninvas
ventil
exclud
comparison
use
noninvas
ventil
pic
window
follow
invas
ventil
versu
continu
invas
ventil
includ
type
noninvas
ventil
deliv
nasaloronas
cannula
full
face
mask
provid
ventilatori
support
flow
gener
identifi
ventil
mode
elig
review
conven
meet
involv
panel
clinician
west
china
hospit
expertis
exacerb
copd
breath
dysregul
pulmonari
infect
ventil
critic
care
clinic
expert
investig
identifi
possibl
outcom
relat
invas
ventil
noninvas
ventil
outcom
determin
consensu
formal
feedback
survey
rate
clinic
import
outcom
assign
valu
lowest
import
highest
import
result
use
gener
mean
score
standard
deviat
sd
outcom
import
outcom
classifi
accord
mean
score
three
outcom
categori
identifi
base
clinic
import
critic
mean
score
import
critic
mean
score
limit
import
mean
score
critic
import
outcom
use
make
recommend
shown
tabl
conduct
extens
literatur
search
identifi
publish
studi
use
follow
electron
databas
cochran
central
regist
control
trial
central
ovid
medlin
ovid
embas
ovid
chines
biomedicin
databas
cbm
china
nation
knowledg
infrastructur
cnki
vip
inform
databas
wan
fang
databas
search
term
medlin
ovid
list
appendix
strategi
devis
appropri
requir
databas
scan
refer
list
elig
studi
find
relev
public
fulfil
inclus
criteria
also
retriev
confer
proceed
dissert
abstract
identifi
unpublish
studi
retriev
record
includ
titl
abstract
screen
independ
review
author
lp
pwr
use
endnot
softwar
remov
duplic
studi
select
accord
predefin
criteria
full
text
elig
studi
download
discrep
resolv
via
discuss
consult
lead
review
dyk
predevelop
form
use
extract
follow
data
identifi
studi
independ
investig
lp
xtl
first
author
public
year
sampl
size
group
characterist
particip
includ
age
sex
sever
entri
copd
stage
diagnosi
criteria
copd
detail
noninvas
invas
ventil
measur
outcom
followup
avail
number
reason
miss
particip
mean
score
chang
baselin
particular
endpoint
also
abstract
avail
report
extract
mean
score
baselin
endpoint
well
sd
consensu
obtain
discuss
consult
lead
review
dyk
cochran
collabor
risk
bia
tool
use
apprais
risk
bia
elig
studi
review
lp
pwr
independ
judg
whether
follow
domain
adequ
met
random
sequenc
gener
alloc
conceal
blind
particip
personnel
outcom
assessor
incomplet
outcom
data
select
outcom
report
disagr
arbitr
discuss
lead
review
dyk
quantit
data
aggreg
metaanalys
use
review
manag
dichotom
data
pool
effect
estim
calcul
use
risk
ratio
rr
confid
interv
ci
continu
data
overal
treatment
effect
size
calcul
use
mean
differ
md
ci
rate
scale
use
use
standard
mean
differ
rate
scale
differ
p
consid
threshold
statist
signific
heterogen
across
studi
result
assess
use
cochran
q
statist
p
valu
statist
use
quantifi
degre
heterogen
p
indic
signific
heterogen
present
randomeffect
model
appli
pool
overal
effect
estim
otherwis
fixedeffect
model
use
subgroup
analys
carri
avail
investig
potenti
influenc
clinic
characterist
particip
methodolog
qualiti
treatment
effect
size
sensit
analys
perform
avail
explor
possibl
heterogen
impact
robust
studi
result
number
includ
studi
suffici
n
funnel
plot
gener
detect
potenti
public
bia
qualiti
evid
specif
outcom
among
includ
studi
evalu
use
grade
approach
two
author
xtl
lp
receiv
train
use
grade
pro
cochran
colloquium
hyderabad
india
septemb
separ
assess
qualiti
estim
outcom
evid
qualiti
across
outcom
upgrad
downgrad
determin
primari
domain
risk
bia
inconsist
indirect
imprecis
public
bia
eventu
categor
level
high
moder
low
low
tabl
show
characterist
identifi
trial
elig
studi
carri
china
publish
chines
mean
sampl
size
studi
rang
particip
year
arf
due
acut
exacerb
copd
male
approxim
account
half
total
patient
studi
dropout
observ
studi
aecopd
diagnost
criteria
base
guidelin
diagnosi
treatment
copd
revis
global
strategi
diagnosi
manag
prevent
copd
revis
pic
window
select
time
replac
invas
ventil
noninvas
support
among
trial
ventil
mode
variou
includ
studi
identifi
trial
prone
methodolog
qualiti
issu
item
regard
random
sequenc
gener
alloc
conceal
judg
unclear
inadequ
report
may
rais
potenti
risk
select
bia
one
studi
use
random
number
tabl
produc
random
sequenc
wherea
trial
report
randomli
assign
mention
sequenc
produc
detail
alloc
conceal
unclear
studi
owe
natur
invas
ventil
noninvas
ventil
possibl
blind
particip
healthcar
provid
meanwhil
whether
import
risk
bia
exist
could
assess
pauciti
data
among
includ
trial
sixteen
studi
includ
patient
report
mortal
mortal
occur
hospit
caus
among
trial
compar
invas
ventil
pool
estim
indic
noninvas
ventil
reduc
mortal
significantli
rr
ci
p
without
signific
heterogen
p
fig
trial
provid
proport
particip
develop
vap
signific
reduct
incid
vap
observ
group
noninvas
ventil
rr
ci
p
amidst
heterogen
p
fig
six
studi
report
proport
wean
failur
review
result
metaanalysi
indic
signific
decreas
wean
failur
observ
patient
use
noninvas
ventil
rr
ci
p
without
heterogen
p
fig
six
trial
report
proport
reintub
pool
metaanalysi
strong
evid
noninvas
ventil
could
significantli
decreas
proport
reintub
rr
ci
p
absenc
heterogen
p
fig
trial
compar
durat
invas
ventil
group
signific
reduct
durat
invas
ventil
patient
use
noninvas
ventil
observ
md
ci
p
signific
heterogen
found
p
fig
randomeffect
metaanalysi
indic
signific
reduct
total
durat
mechan
ventil
within
noninvas
group
md
ci
p
accompani
high
heterogen
p
fig
ten
trial
involv
particip
provid
length
stay
lo
intens
care
unit
icu
summari
estim
indic
noninvas
ventil
significantli
shorten
icu
stay
day
md
ci
p
sever
heterogen
p
fig
data
studi
report
lo
hospit
pool
compar
invas
ventil
noninvas
ventil
significantli
reduc
hospit
stay
day
md
ci
p
consider
heterogen
p
fig
studi
enrol
particip
compar
hospit
cost
group
aggreg
data
demonstr
signific
reduct
hospit
cost
us
dollar
convert
chines
yuan
us
dollar
favor
noninvas
group
md
ci
p
substanti
heterogen
p
fig
one
studi
use
test
compar
number
particip
occur
complic
number
particip
requir
tracheotomi
within
group
respect
result
indic
signific
differ
found
p
howev
patient
receiv
noninvas
ventil
less
complic
requir
tracheotomi
receiv
invas
ventil
one
studi
report
patient
develop
facial
skin
flush
patient
present
abdomin
distens
two
particip
appear
gastric
distens
particip
present
slight
facial
hyperemia
noninvas
ventil
one
studi
ten
patient
occur
abdomin
distens
patient
occur
facial
injuri
noninvas
ventil
studi
rest
trial
report
advers
event
funnel
plot
outcom
vap
via
visual
inspect
present
signific
asymmetri
indic
potenti
risk
public
bia
fig
one
studi
gener
random
sequenc
use
random
number
tabl
wherea
includ
studi
fail
report
suffici
inform
enabl
conclus
respect
whether
random
sequenc
gener
alloc
conceal
outcom
data
adequ
insuffici
report
increas
potenti
select
bia
therefor
rate
qualiti
evid
outcom
regard
follow
outcom
durat
invas
ventil
total
durat
mechan
ventil
lo
icu
lo
hospit
hospit
cost
statist
heterogen
note
metaanalysi
result
consid
level
inconsist
seriou
downgrad
evid
qualiti
outcom
includ
studi
directli
compar
noninvas
ventil
use
pic
window
versu
continu
invas
ventil
patient
arf
measur
outcom
import
patient
consider
differ
exist
studi
popul
outcom
measur
determin
indirect
seriou
critic
outcom
reintub
although
ci
exclud
rel
risk
includ
appreci
benefit
harm
rel
risk
rough
guid
total
number
patient
metaanalysi
n
fail
meet
optim
inform
size
oi
criterion
estim
approxim
downgrad
qualiti
evid
imprecis
potenti
public
bia
detect
funnel
plot
outcom
vap
subsequ
rate
evid
qualiti
outcom
seventeen
rct
involv
patient
identifi
review
metaanalys
indic
use
noninvas
ventil
pic
window
could
significantli
reduc
mortal
vap
wean
failur
reintub
durat
invas
ventil
total
durat
mechan
ventil
lo
icu
lo
hospit
well
hospit
cost
meanwhil
less
advers
event
observ
patient
receiv
noninvas
ventil
receiv
continu
invas
ventil
prolong
invas
ventil
posit
relat
vap
persist
wean
failur
may
occur
consequ
mortal
probabl
increas
subsequ
noninvas
ventil
appli
nasal
oronas
cannula
full
facial
mask
need
artifici
airway
provid
partial
ventilatori
support
patient
obtain
abil
continu
spontan
breath
still
requir
ventil
support
studi
found
time
extub
immedi
use
noninvas
ventil
significantli
reduc
durat
invas
ventil
day
consequ
incid
vap
mortal
reduc
higher
success
wean
rate
also
observ
meantim
total
durat
mechan
ventil
decreas
day
reus
tracheal
tube
may
exacerb
exist
damag
tracheal
mucosa
noninvas
ventil
requir
tracheal
intub
cough
reflex
henc
preserv
appli
patient
respiratori
failur
effect
improv
oxygen
ventil
reduc
reintub
rate
studi
also
prove
patient
use
noninvas
ventil
occur
less
reintub
receiv
invas
ventil
import
benefit
noninvas
ventil
includ
reduct
vap
length
icu
hospit
stay
close
associ
medic
cost
strong
evid
indic
noninvas
ventil
costeffect
greatest
cost
benefit
reduct
us
dollar
mainli
owe
reduct
vap
avoid
icu
hospit
admiss
trial
includ
review
select
pic
window
switch
point
pulmonari
infect
main
caus
acut
exacerb
copd
china
appear
pic
window
demonstr
pulmonari
infect
significantli
control
henc
airway
secret
drainag
main
issu
patient
probabl
requir
tracheal
tube
time
remov
endotrach
tube
applic
noninvas
ventil
period
time
might
continu
suppli
ventil
support
allevi
respiratori
muscl
fatigu
also
avoid
associ
infect
reduc
durat
invas
ventil
found
benefici
effect
use
noninvas
ventil
time
assess
outcom
review
meanwhil
need
highlight
accur
judg
presenc
pic
window
immedi
chang
invas
support
noninvas
ventil
clinician
clearli
understand
criteria
window
care
observ
clinic
characterist
patient
monitor
indic
pic
window
miss
window
vap
might
occur
later
patient
condit
would
relaps
durat
invas
ventil
would
prolong
result
ventil
depend
consequ
wean
failur
addit
success
use
noninvas
ventil
patient
larg
depend
clinician
experi
number
publish
studi
show
noninvas
ventil
perform
highli
motiv
experienc
care
team
often
work
effect
arf
wherea
less
experienc
use
noninvas
ventil
often
led
higher
reintub
rate
therefor
appli
welltrain
highli
skill
medic
staff
avoid
intoler
common
advers
effect
use
grade
approach
rate
qualiti
evid
prespecifi
outcom
review
report
qualiti
gener
poor
consequ
unclear
random
alloc
conceal
may
lead
potenti
possibl
select
bia
qualiti
evid
influenc
consider
heterogen
outcom
durat
invas
ventil
total
durat
mechan
ventil
lo
icu
lo
hospit
hospit
cost
substanti
heterogen
may
aris
chang
condit
patient
blood
ga
analysi
ventil
indirectli
reflect
differ
ventil
mode
studi
use
simv
psv
peep
studi
use
ac
simv
psv
studi
use
simv
psv
inconsist
relat
patient
clinic
characterist
treatment
reason
downgrad
one
level
evid
regard
imprecis
addit
ci
line
effect
appreci
benefit
harm
anoth
criterion
oi
also
determin
guarante
adequ
precis
oi
refer
number
particip
estim
sampl
size
calcul
singl
adequ
power
trial
total
number
particip
metaanalysi
lower
oi
criterion
qualiti
evid
downgrad
imprecis
studi
although
ci
outcom
reintub
exclud
rel
risk
appreci
harm
total
number
particip
n
metaanalysi
exceed
oi
n
therefor
like
support
decis
downgrad
evid
qualiti
due
impress
substanti
differ
exist
patient
baselin
characterist
outcom
measur
includ
studi
consid
indirect
seriou
potenti
public
bia
detect
regard
outcom
vap
visual
inspect
qualiti
evid
outcom
rate
overal
qualiti
evid
respect
critic
import
outcom
grade
moder
low
uncertainti
longterm
effect
like
warrant
weak
recommend
noninvas
ventil
use
pic
window
arf
aecopd
patient
includ
rct
ensur
studi
potenti
high
qualiti
review
howev
possibl
select
bia
may
introduc
exclud
relev
studi
quasirct
observ
studi
select
bia
also
may
occur
methodolog
design
includ
studi
due
inadequ
report
although
review
process
apprais
rigor
experienc
independ
author
liu
et
al
notic
asian
peopl
includ
chines
prone
publish
high
proport
posit
find
given
trial
report
neg
result
funnel
plot
detect
presenc
signific
asymmetri
studi
suscept
public
bia
within
review
develop
explicit
elig
criteria
use
pico
particip
intervent
comparison
outcom
studi
design
format
carri
extens
rigor
literatur
search
identifi
relev
studi
assess
risk
bia
duplic
also
aggreg
overal
effect
size
critic
import
outcom
best
knowledg
review
first
appli
grade
approach
apprais
qualiti
evid
gener
recommend
regard
use
noninvas
intervent
pic
window
arf
aecopd
patient
addit
review
offer
potenti
opportun
reader
unabl
get
access
read
origin
articl
publish
chines
could
also
help
addit
public
may
provid
sound
basi
futur
clinic
research
issu
noninvas
ventil
pic
window
nevertheless
sever
limit
special
address
accept
find
note
studi
use
power
calcul
estim
optim
sampl
size
gave
comment
sampl
size
one
studi
includ
particip
doubt
whether
small
sampl
size
enough
achiev
adequ
statist
power
detect
differ
noninvas
ventil
group
invas
ventil
group
addit
includ
trial
conduct
china
mainli
approxim
copd
patient
caus
pulmonari
infect
china
pic
window
identifi
chines
research
wang
et
al
time
extub
period
time
might
precis
judg
use
noninvas
ventil
may
improv
treatment
efficaci
howev
whether
still
effect
could
appli
patient
outsid
china
still
need
investig
one
cochran
review
evalu
studi
compar
effect
safeti
immedi
use
noninvas
ventil
continu
invas
ventil
arf
patient
author
includ
patient
arf
caus
copd
noncopd
postop
nonop
select
time
use
noninvas
ventil
spontan
breath
trial
failur
tpiec
trial
failur
pic
window
found
noninvas
ventil
significantli
reduc
mortal
wean
failur
vap
lo
icu
forth
howev
separ
investig
impact
noninvas
ventil
use
pic
window
arf
due
copd
review
specif
address
copd
particip
pic
window
found
benefici
effect
intervent
prior
metaanalysi
explor
effect
noninvas
ventil
use
pic
window
arf
copd
patient
author
retriev
databas
pubm
cnki
includ
outcom
mortal
vap
invas
ventil
time
compar
review
search
electron
databas
gray
literatur
databas
well
refer
list
identifi
critic
import
outcom
use
grade
assess
qualiti
evid
regard
outcom
search
relev
databas
incept
octob
review
may
consid
uptod
evid
issu
comprehens
robust
draw
conclus
current
evid
synthes
identifi
trial
suggest
noninvas
ventil
use
pic
window
significantli
reduc
mortal
vap
wean
failur
reintub
durat
invas
ventil
total
durat
mechan
ventil
lo
icu
lo
hospit
well
hospit
cost
given
absenc
high
qualiti
avail
evid
addit
welldesign
adequ
power
rct
requir
recommend
clinic
practic
consider
taken
adopt
pic
window
extub
suggest
perform
prior
welltrain
highli
experienc
treatment
provid
meanwhil
immedi
choos
appropri
type
oronas
cannula
total
face
mask
consid
identifi
studi
carri
china
rigor
design
largescal
rct
outsid
china
warrant
improv
generaliz
applic
studi
result
futur
studi
report
harm
data
withdraw
due
advers
effect
recommend
futur
studi
investig
longterm
effect
noninvas
ventil
qualiti
life
futur
trial
also
report
accord
consolid
standard
report
trial
statement
improv
qualiti
report
